Co-Lab at Burjeel Cancer Institute is a state-of-the-art diagnostic and research facility integrating Onco-Helix for next-generation oncology testing. Equipped with Total Lab Automation (TLA) and Infinity Lab Solutions, it provides real-time, high-precision cancer diagnostics, ensuring oncologists have the most advanced tools for personalized treatment planning. Onco-Helix specializes in molecular genetics, tumor biomarker profiling, and immunological assays, making it a cornerstone of precision oncology. This innovative platform enables early cancer detection, risk stratification, and biomarker-driven treatment selection to ensure patients receive the most effective and tailored therapies.
Conditions Diagnosed & Monitored
- Solid Tumors: Breast, Lung, Colorectal, Pancreatic, Prostate, Ovarian, and more.
- Hematologic Malignancies: Leukemia, Lymphoma, Multiple Myeloma.
- Hereditary Cancer Syndromes: BRCA mutations, Lynch Syndrome.
- Rare & Unknown Primary Tumors: Advanced molecular profiling for complex cases.
Key Services & Capabilities
Molecular Oncology & Genomic Testing (Onco-Helix)
Next-Generation Sequencing (NGS) for tumor genetic profiling, Comprehensive Genomic Panels to identify targeted therapy options, BRCA1/BRCA2 and Hereditary Cancer Screening for familial risk assessment and Liquid Biopsy for Non-Invasive Tumor Monitoring (Circulating Tumor DNA - ctDNA).
Immuno-Oncology & Tumor Microenvironment Analysis
PD-L1, Microsatellite Instability (MSI), Tumor Mutational Burden (TMB) testing to assess immunotherapy eligibility and Multiplex Immunohistochemistry (mIHC) for advanced immune profiling.
Advanced Pathology & Digital Imaging
AI-Powered Digital Pathology for rapid, high-accuracy cancer diagnostics and Frozen Section & Real-Time Tumor Margin Analysis for intraoperative precision.
Hematopathology & Bone Marrow Diagnostics
Flow Cytometry for Leukemia and Lymphoma Classification and Bone Marrow Biopsy and Cytogenetic Testing.
Personalized Treatment Planning & Precision Medicine
AI-Driven Predictive Analytics to match patients with optimal targeted therapies and Customized Cancer Treatment Plans based on genetic, molecular, and immune profiling.
Our Approach to Precision Oncology
Multidisciplinary Team Collaboration
Oncologists, geneticists, and pathologists work together for optimal treatment strategies.
AI-Enhanced Diagnostic Decision Support
Machine-learning algorithms refine and predict cancer treatment responses.
Comprehensive, Personalized Reports
Detailed insights to guide oncologists in selecting the most effective therapies.
Continuous Monitoring & Adaptive Treatment
Real-time biomarker tracking to adjust therapies as needed.
Technologies & Innovations at Co-Lab & Onco-Helix
Total Lab Automation (TLA)
Robotic workflow optimizing efficiency and accuracy.
Infinity Lab Solution
AI-enhanced analytics for rapid diagnostic insights.
High-Throughput NGS Sequencing
Cutting-edge technology for precision oncology.
Digital Pathology & AI Diagnostics
Automated image analysis for faster and more accurate results.
Multiplex Biomarker Testing
Simultaneous detection of multiple tumor markers.
Patient Journey with Co-Lab & Onco-Helix
Initial Consultation & Test Recommendation.
Oncologists evaluate patient history and determine the required tests.
Sample Collection & Advanced Processing.
Blood, tissue, or genetic samples undergo high-precision analysis.
AI-Driven Genomic & Immunological Analysis.
Cutting-edge sequencing and biomarker profiling for treatment selection.
Personalized Precision Medicine Report.
Results integrated into a customized oncology treatment plan.
Ongoing Monitoring & Adaptive Therapy Adjustments.
